Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization

W. Ray Kim, Russell H. Wiesner, John J. Poterucha, Terry M Therneau, Michael Malinchoc, Joanne T. Benson, Jeffrey S. Crippin, Goran B G Klintmalm, Jorge Rakela, Thomas E. Starzl, Ruud A F Krom, Roger W. Evans, E. Rolland Dickson

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The aim of our study was to quantitatively assess the impact of hepatic retransplantation on patient and graft survival and resource utilization. We studied patients undergoing hepatic retransplantation among 447 transplant recipients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) at 3 transplantation centers. Cox proportional hazards regression analysis was used for survival analysis. Measures of resource utilization included the duration of hospitalization, length of stay in the intensive care unit, and the duration of transplantation surgery. Forty-six (10.3%) patients received 2 or more grafts during the follow-up period (median, 2.8 years). Patients who underwent retransplantation had a 3.8-fold increase in the risk of death compared with those without retransplantation (P < .01). Retransplantation after an interval of greater than 30 days from the primary graft was associated with a 6.7-fold increase in the risk of death (P < .01). The survival following retransplantations performed 30 days or earlier was similar to primary transplantations. Resource utilization was higher in patients who underwent multiple consecutive transplantations, even after adjustment for the number of grafts during the hospitalization. Among cholestatic liver disease patients, poor survival following hepatic retransplantation is attributed to late retransplantations, namely those performed more than 30 days after the initial transplantation. While efforts must be made to improve the outcome following retransplantation, a more critical evaluation may be warranted for late retransplantation candidates.

Original languageEnglish (US)
Pages (from-to)395-400
Number of pages6
JournalHepatology
Volume30
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Liver Diseases
Transplantation
Survival
Liver
Transplants
Hospitalization
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Graft Survival
Survival Analysis
Intensive Care Units
Length of Stay
Regression Analysis

ASJC Scopus subject areas

  • Hepatology

Cite this

Hepatic retransplantation in cholestatic liver disease : Impact of the interval to retransplantation on survival and resource utilization. / Kim, W. Ray; Wiesner, Russell H.; Poterucha, John J.; Therneau, Terry M; Malinchoc, Michael; Benson, Joanne T.; Crippin, Jeffrey S.; Klintmalm, Goran B G; Rakela, Jorge; Starzl, Thomas E.; Krom, Ruud A F; Evans, Roger W.; Dickson, E. Rolland.

In: Hepatology, Vol. 30, No. 2, 1999, p. 395-400.

Research output: Contribution to journalArticle

Kim, WR, Wiesner, RH, Poterucha, JJ, Therneau, TM, Malinchoc, M, Benson, JT, Crippin, JS, Klintmalm, GBG, Rakela, J, Starzl, TE, Krom, RAF, Evans, RW & Dickson, ER 1999, 'Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization', Hepatology, vol. 30, no. 2, pp. 395-400. https://doi.org/10.1002/hep.510300210
Kim, W. Ray ; Wiesner, Russell H. ; Poterucha, John J. ; Therneau, Terry M ; Malinchoc, Michael ; Benson, Joanne T. ; Crippin, Jeffrey S. ; Klintmalm, Goran B G ; Rakela, Jorge ; Starzl, Thomas E. ; Krom, Ruud A F ; Evans, Roger W. ; Dickson, E. Rolland. / Hepatic retransplantation in cholestatic liver disease : Impact of the interval to retransplantation on survival and resource utilization. In: Hepatology. 1999 ; Vol. 30, No. 2. pp. 395-400.
@article{a331e3ae7ae04083822479e937a3b816,
title = "Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization",
abstract = "The aim of our study was to quantitatively assess the impact of hepatic retransplantation on patient and graft survival and resource utilization. We studied patients undergoing hepatic retransplantation among 447 transplant recipients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) at 3 transplantation centers. Cox proportional hazards regression analysis was used for survival analysis. Measures of resource utilization included the duration of hospitalization, length of stay in the intensive care unit, and the duration of transplantation surgery. Forty-six (10.3{\%}) patients received 2 or more grafts during the follow-up period (median, 2.8 years). Patients who underwent retransplantation had a 3.8-fold increase in the risk of death compared with those without retransplantation (P < .01). Retransplantation after an interval of greater than 30 days from the primary graft was associated with a 6.7-fold increase in the risk of death (P < .01). The survival following retransplantations performed 30 days or earlier was similar to primary transplantations. Resource utilization was higher in patients who underwent multiple consecutive transplantations, even after adjustment for the number of grafts during the hospitalization. Among cholestatic liver disease patients, poor survival following hepatic retransplantation is attributed to late retransplantations, namely those performed more than 30 days after the initial transplantation. While efforts must be made to improve the outcome following retransplantation, a more critical evaluation may be warranted for late retransplantation candidates.",
author = "Kim, {W. Ray} and Wiesner, {Russell H.} and Poterucha, {John J.} and Therneau, {Terry M} and Michael Malinchoc and Benson, {Joanne T.} and Crippin, {Jeffrey S.} and Klintmalm, {Goran B G} and Jorge Rakela and Starzl, {Thomas E.} and Krom, {Ruud A F} and Evans, {Roger W.} and Dickson, {E. Rolland}",
year = "1999",
doi = "10.1002/hep.510300210",
language = "English (US)",
volume = "30",
pages = "395--400",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Hepatic retransplantation in cholestatic liver disease

T2 - Impact of the interval to retransplantation on survival and resource utilization

AU - Kim, W. Ray

AU - Wiesner, Russell H.

AU - Poterucha, John J.

AU - Therneau, Terry M

AU - Malinchoc, Michael

AU - Benson, Joanne T.

AU - Crippin, Jeffrey S.

AU - Klintmalm, Goran B G

AU - Rakela, Jorge

AU - Starzl, Thomas E.

AU - Krom, Ruud A F

AU - Evans, Roger W.

AU - Dickson, E. Rolland

PY - 1999

Y1 - 1999

N2 - The aim of our study was to quantitatively assess the impact of hepatic retransplantation on patient and graft survival and resource utilization. We studied patients undergoing hepatic retransplantation among 447 transplant recipients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) at 3 transplantation centers. Cox proportional hazards regression analysis was used for survival analysis. Measures of resource utilization included the duration of hospitalization, length of stay in the intensive care unit, and the duration of transplantation surgery. Forty-six (10.3%) patients received 2 or more grafts during the follow-up period (median, 2.8 years). Patients who underwent retransplantation had a 3.8-fold increase in the risk of death compared with those without retransplantation (P < .01). Retransplantation after an interval of greater than 30 days from the primary graft was associated with a 6.7-fold increase in the risk of death (P < .01). The survival following retransplantations performed 30 days or earlier was similar to primary transplantations. Resource utilization was higher in patients who underwent multiple consecutive transplantations, even after adjustment for the number of grafts during the hospitalization. Among cholestatic liver disease patients, poor survival following hepatic retransplantation is attributed to late retransplantations, namely those performed more than 30 days after the initial transplantation. While efforts must be made to improve the outcome following retransplantation, a more critical evaluation may be warranted for late retransplantation candidates.

AB - The aim of our study was to quantitatively assess the impact of hepatic retransplantation on patient and graft survival and resource utilization. We studied patients undergoing hepatic retransplantation among 447 transplant recipients with primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) at 3 transplantation centers. Cox proportional hazards regression analysis was used for survival analysis. Measures of resource utilization included the duration of hospitalization, length of stay in the intensive care unit, and the duration of transplantation surgery. Forty-six (10.3%) patients received 2 or more grafts during the follow-up period (median, 2.8 years). Patients who underwent retransplantation had a 3.8-fold increase in the risk of death compared with those without retransplantation (P < .01). Retransplantation after an interval of greater than 30 days from the primary graft was associated with a 6.7-fold increase in the risk of death (P < .01). The survival following retransplantations performed 30 days or earlier was similar to primary transplantations. Resource utilization was higher in patients who underwent multiple consecutive transplantations, even after adjustment for the number of grafts during the hospitalization. Among cholestatic liver disease patients, poor survival following hepatic retransplantation is attributed to late retransplantations, namely those performed more than 30 days after the initial transplantation. While efforts must be made to improve the outcome following retransplantation, a more critical evaluation may be warranted for late retransplantation candidates.

UR - http://www.scopus.com/inward/record.url?scp=0032811404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032811404&partnerID=8YFLogxK

U2 - 10.1002/hep.510300210

DO - 10.1002/hep.510300210

M3 - Article

C2 - 10421646

AN - SCOPUS:0032811404

VL - 30

SP - 395

EP - 400

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 2

ER -